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To clarify the role of 5-HT2C receptors in the generation of
epilepsy this study investigated the effects of the 5-HT2C
receptor-preferring agonist 1-(m-chlorophenyl)-pipera-
zine (mCPP) and the subtype-selective 5-HT2C receptor
antagonist SB 242084 in pentylenetetrazole (PTZ)-evoked
seizures in mice. All drugs were given subcutaneously
(s.c.) 60 minutes before PTZ injection (100 mg/kg s.c.).
The seizure patterns were recorded during a 60 min period
following the injection of PTZ. The following parameters
were evaluated: survival rate, duration of survival, seizure
latency, seizure level (from 0 to 4) and seizure duration.
The activity score for each mouse was defined as the sei-
zure duration time-weighted average of the seizure levels.
The significance of the survival rate was assessed by the
Chi-square test, for the other parameters we applied one-
way ANOVA. mCPP (1, 5 and 25 mg/kg s.c.) significantly
increased the rate and the duration of survival and
changed the pattern of seizure levels. These effects fol-
lowed a bell-shaped dose-response curve and were com-
pletely abolished by 5 mg/kg of SB 242084, although the
antagonist alone did not modify the seizure parameters.
These results indicate that the anticonvulsant effects of
mCPP might be mediated by activation of 5-HT2C recep-
tors. However, the lack of the effect of the selective antag-
onist SB 242084 (1, 2.5 and 5 mg/kg s.c.) on the seizure
parameters suggests that the function of this 5-HT recep-
tor subtype depends on the level of 5-HT tone.
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